Global Cas Nuclease Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cas Nuclease Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Cas Nuclease report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cas Nuclease market is projected to reach US$ 821.1 million in 2034, increasing from US$ 146.5 million in 2022, with the CAGR of 27.8% during the period of 2024 to 2034. Demand from Gene Editing Cell Line Construction and Animal Models are the major drivers for the industry.
The main manufacturers of Cas nuclease include Thermo Fisher Scientific, GenScript and Integrated DNA Technologies, Inc., etc. The top three manufacturers account for about 45% of the share. North America is the largest market with about 44% share, followed by Europe and China with about 35% and 8% of the market. Cas9 is the largest segment with an 85% share. Gene editing cell line construction was the largest application with about 40% share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cas Nuclease market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific
GenScript
Integrated DNA Technologies, Inc.
Aldevron
Merck
Horizon Discovery
Agilent
OriGene Technologies, Inc
New England Biolabs
NIPPON GENE CO., LTD.
Novoprotein
Applied Biological Materials Inc. (abm)
Segment by Type
Cas9
Cas12
Cas13
Others
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cas Nuclease market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Cas Nuclease introduction, etc. Cas Nuclease Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Cas Nuclease market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
The main manufacturers of Cas nuclease include Thermo Fisher Scientific, GenScript and Integrated DNA Technologies, Inc., etc. The top three manufacturers account for about 45% of the share. North America is the largest market with about 44% share, followed by Europe and China with about 35% and 8% of the market. Cas9 is the largest segment with an 85% share. Gene editing cell line construction was the largest application with about 40% share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cas Nuclease market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific
GenScript
Integrated DNA Technologies, Inc.
Aldevron
Merck
Horizon Discovery
Agilent
OriGene Technologies, Inc
New England Biolabs
NIPPON GENE CO., LTD.
Novoprotein
Applied Biological Materials Inc. (abm)
Segment by Type
Cas9
Cas12
Cas13
Others
Segment by Application
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cas Nuclease market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Cas Nuclease introduction, etc. Cas Nuclease Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Cas Nuclease market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.